Sparsentan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 107 publications
Comment on "Assessing the real-world safety of sparsentan for immunoglobulin A nephropathy: insights from a comprehensive analysis of FAERS database".
Journal: International urology and nephrology
Published: March 03, 2026
The latest pharmacotherapeutic options for the treatment of IgA nephropathy in the pediatric population.
Journal: Expert opinion on pharmacotherapy
Published: January 20, 2026
Emerging Therapies in IgA Nephropathy: From A Proliferation-Inducing Ligand (APRIL) and B-cell Activating Factor (BAFF) Inhibitors to Precision Medicine.
Journal: Cureus
Published: December 21, 2025
Assessing the real-world safety of sparsentan for immunoglobulin A nephropathy: insights from a comprehensive analysis of FAERS database.
Journal: International urology and nephrology
Published: December 08, 2025
Matching-adjusted indirect comparison of kidney function in patients with immunoglobulin A nephropathy treated with nefecon or sparsentan.
Journal: Journal of comparative effectiveness research
Published: November 20, 2025
Prevalence, resource utilization, and economic impact of kidney function and proteinuria in patients with focal segmental glomerulosclerosis.
Journal: The American journal of managed care
Published: November 12, 2025
IgA Nephropathy: An Overview of the Clinical Trials.
Journal: Kidney medicine
Published: October 06, 2025
Treatment of Recurrent IgA Nephropathy After Kidney Transplantation: Case Report and Comprehensive Literature Review.
Journal: Clinical case reports
Published: September 24, 2025
In brief: Embryotoxicity REMS removal for endothelin receptor antagonists.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Successful targeting of the alternative complement cascade with iptacopan for the treatment of IgA nephropathy: a case report.
Journal: Swiss medical weekly
Published: August 14, 2025
Last Updated: 04/28/2026